期刊文献+

非甾体抗炎药的近况 被引量:16

下载PDF
导出
作者 佘庆生
出处 《上海医药》 CAS 2005年第6期263-265,共3页 Shanghai Medical & Pharmaceutical Journal
  • 相关文献

参考文献1

二级参考文献6

  • 1[1]Singh G,Rosen D. NSAID-induced gastrointestinal complications[J].The Aramis Perspective,1997,25(suppl 51):8.
  • 2[2]O'Banion MK, Winn VD,et al. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase[J]. Proc Natl Acad Sci, 1992,89:4888.
  • 3[3]O'Banion MK, Sadowski HB,Winn V,Young DA.A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-regulated protein[J]. J Biol Chem,1991,266:23261.
  • 4[4]American Rheumatism Association (ARA) Glossary Committee[M]. Dictionary of the Rheumatic Diseases, Vol.1: Signs and Symptoms. New York, NY, Contact Associates International, 1998.
  • 5[5]Cannon G,Caldwell J,Holt P,et al. MK-0966,a specific COX-2 inhibitor,has clinical efficacy comparable to diclofenac in the treatment of knee and hip osteoarthritis(OA) in a 26-week controlled clinical trial [abstract no. 983][J]. Arthritis Rheum, 1998, 41 Suppl:S196.
  • 6[6]Truitt K, Ettinger W, Schnitzer T, et al. Rofecoxib, a COX-2 specific inhibitor, had clinical efficacy and overall safety in treating osteoarthritis patients 80 years and older[abstract no. 895]. In: XIV European League Against Rheumatism Congress, 1999, 6-11:Glasgow.

共引文献11

同被引文献162

引证文献16

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部